These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 29868715)
21. The effects of state rules on opioid prescribing in Indiana. Al Achkar M; Grannis S; Revere D; MacKie P; Howard M; Gupta S BMC Health Serv Res; 2018 Jan; 18(1):29. PubMed ID: 29347984 [TBL] [Abstract][Full Text] [Related]
22. The Effect of a Statewide Mandatory Prescription Drug Monitoring Program on Opioid Prescribing by Emergency Medicine Providers Across 15 Hospitals in a Single Health System. Suffoletto B; Lynch M; Pacella CB; Yealy DM; Callaway CW J Pain; 2018 Apr; 19(4):430-438. PubMed ID: 29241835 [TBL] [Abstract][Full Text] [Related]
23. Effect of Controlled Substance Use Management on Prescribing Patterns and Health Outcomes Among High-Risk Users. Chen X; Ma Q; Barron J; DeVries A; Horn J; Agiro A J Manag Care Spec Pharm; 2019 Mar; 25(3):392-401. PubMed ID: 30816820 [TBL] [Abstract][Full Text] [Related]
24. The Concentration of Opioid Prescriptions by Providers and Among Patients in the Oregon Medicaid Program. Kim H; Hartung DM; Jacob RL; McCarty D; McConnell KJ Psychiatr Serv; 2016 Apr; 67(4):397-404. PubMed ID: 26766755 [TBL] [Abstract][Full Text] [Related]
25. Evaluating Emergency Department Opioid Prescribing Behaviors After Education About Mandated Use of the Pennsylvania Prescription Drug Monitoring Program. Martello J; Cassidy B; Mitchell A J Addict Nurs; 2018; 29(3):196-202. PubMed ID: 30180006 [TBL] [Abstract][Full Text] [Related]
26. Impact evaluation of a brief online training module on physician use of the Maryland, USA, Prescription Drug Monitoring Program. Adenaiye OO; Zirpoli JB; Tan M; Day BF; Bolaji O; Mitchell CS; Cloeren M PLoS One; 2022; 17(8):e0272217. PubMed ID: 35944051 [TBL] [Abstract][Full Text] [Related]
27. How Are Real-time Opioid Prescribing Cognitions by Emergency Providers Influenced by Reviewing the State Prescription Drug Monitoring Program? Landau A; Lynch M; Callaway C; Suffoletto B Pain Med; 2019 May; 20(5):955-960. PubMed ID: 29762757 [TBL] [Abstract][Full Text] [Related]
28. Provider Reactions to Opioid-Prescribing Report Cards. Alishahi ML; Olson K; Brooks-Russell A; Hoppe J; Runyan C J Public Health Manag Pract; 2022 Mar-Apr 01; 28(2):E518-E524. PubMed ID: 34016911 [TBL] [Abstract][Full Text] [Related]
29. Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study. Radomski TR; Bixler FR; Zickmund SL; Roman KM; Thorpe CT; Hale JA; Sileanu FE; Hausmann LRM; Thorpe JM; Suda KJ; Stroupe KT; Gordon AJ; Good CB; Fine MJ; Gellad WF J Gen Intern Med; 2018 Aug; 33(8):1253-1259. PubMed ID: 29520747 [TBL] [Abstract][Full Text] [Related]
30. Effectiveness of Prescription Monitoring Programs in Reducing Opioid Prescribing, Dispensing, and Use Outcomes: A Systematic Review. Wilson MN; Hayden JA; Rhodes E; Robinson A; Asbridge M J Pain; 2019 Dec; 20(12):1383-1393. PubMed ID: 31059823 [TBL] [Abstract][Full Text] [Related]
31. Relationship between high-risk patients receiving prescription opioids and high-volume opioid prescribers. Chang HY; Murimi IB; Jones CM; Alexander GC Addiction; 2018 Apr; 113(4):677-686. PubMed ID: 29193546 [TBL] [Abstract][Full Text] [Related]
32. Effect Of A "No Superuser Opioid Prescription" Policy On ED Visits And Statewide Opioid Prescription. Kahler ZP; Musey PI; Schaffer JT; Johnson AN; Strachan CC; Shufflebarger CM West J Emerg Med; 2017 Aug; 18(5):894-902. PubMed ID: 28874942 [TBL] [Abstract][Full Text] [Related]
33. Validation of prescriber risk indicators obtained from prescription drug monitoring program data. Kreiner PW; Strickler GK; Undurraga EA; Torres ME; Nikitin RV; Rogers A Drug Alcohol Depend; 2017 Apr; 173 Suppl 1():S31-S38. PubMed ID: 28363317 [TBL] [Abstract][Full Text] [Related]
34. Advanced visualizations to interpret prescription drug monitoring program information. Weiner SG; Sherritt KM; Tseng Z; Tripathi J Drug Alcohol Depend; 2019 Aug; 201():260-265. PubMed ID: 31276986 [TBL] [Abstract][Full Text] [Related]
35. The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016-2020. Adalbert JR; Syal A; Varshney K; George B; Hom J; Ilyas AM BMC Health Serv Res; 2023 Apr; 23(1):364. PubMed ID: 37046254 [TBL] [Abstract][Full Text] [Related]
36. A typology of prescription drug monitoring programs: a latent transition analysis of the evolution of programs from 1999 to 2016. Smith N; Martins SS; Kim J; Rivera-Aguirre A; Fink DS; Castillo-Carniglia A; Henry SG; Mooney SJ; Marshall BDL; Davis C; Cerdá M Addiction; 2019 Feb; 114(2):248-258. PubMed ID: 30207015 [TBL] [Abstract][Full Text] [Related]
37. How well do doctors know their patients? Evidence from a mandatory access prescription drug monitoring program. Buchmueller TC; Carey CM; Meille G Health Econ; 2020 Sep; 29(9):957-974. PubMed ID: 32790943 [TBL] [Abstract][Full Text] [Related]
38. Prescriber response to unsolicited prescription drug monitoring program reports in Massachusetts. Thomas CP; Kim M; Nikitin RV; Kreiner P; Clark TW; Carrow GM Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):950-7. PubMed ID: 24920376 [TBL] [Abstract][Full Text] [Related]
39. A Systematic Review of Interventions and Programs Targeting Appropriate Prescribing of Opioids. Moride Y; Lemieux-Uresandi D; Castillon G; de Moura CS; Pilote L; Faure M; Bernartsky S Pain Physician; 2019 May; 22(3):229-240. PubMed ID: 31151331 [TBL] [Abstract][Full Text] [Related]
40. Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing. Strickler GK; Zhang K; Halpin JF; Bohnert ASB; Baldwin GT; Kreiner PW Drug Alcohol Depend; 2019 Jun; 199():1-9. PubMed ID: 30954863 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]